MCLAUGHLIN v. GLAXOSMITHKLINE, L.L.C. et al

Filing 40

MEMORANDUM AND ORDER THAT ALL CLAIMS AGAINST DEFENDANTS CADILA HEALTHCARE, ZYBUS PHARMACEUTICALS, AND APOTEX INX. ARE HEREBY DISMISSED WITHOUT PREJUDICE, DEFENDANT'S MOTION TO TRANSFER IS GRANTED. THIS CASE SHALL BE TRANSFERRED TO THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF LOUISIANA. SIGNED BY HONORABLE RONALD L. BUCKWALTER ON 10/17/2012. 10/17/2012 ENTERED AND COPIES E-MAILED.(kk, )

IN THE UNITED STATES DISTRICT COURT
FOR THE EASTERN DISTRICT OF PENNSYLVANIA

CINDA MCLAUGHLIN,
Plaintiff,
v.
GLAXOSMITHKLINE, L.L.C.,
CADILA HEALTHCARE, ZYDUS
PHARMACEUTICALS, and
APOTEX, INC.
Defendant.

:
:
:
:
:
:
:
:
:
:
:
:

CIVIL ACTION

NO. 12-3272

ORDER
AND NOW, this 17th day of October, 2012, upon consideration of (1) the Motion by
Defendant GlaxoSmithKline, LLC. to Transfer Venue to the United States District Court for the
Western District of Louisiana (Docket No. 7), the Response in Opposition by Plaintiff Cinda
McLaughlin (Docket No. 20), Plaintiff’s Supplemental Response in Opposition (Docket No. 25),
Defendant’s Reply Brief in Support (Docket No. 29), and Plaintiff’s Sur-Reply Brief in Opposition
(Docket No. 38); and (2) Plaintiff’s Motions to Voluntarily Dismiss Defendants Cadila Healthcare,
Zydus Pharmaceuticals, and Apotex Inc. (Docket Nos. 34–36), it is hereby ORDERED as follows:
1.

All claims against Defendants Cadila Healthcare, Zydus Pharmaceuticals, and Apotex
Inc. are hereby DISMISSED without prejudice.

2.

Defendant’s Motion to Transfer is GRANTED. This case shall be TRANSFERRED
to the United States District Court for the Western District of Louisiana.

BY THE COURT:

s/ Ronald L. Buckwalter
RONALD L. BUCKWALTER, S.J.